Real-time enrollment status for this schizophrenia clinical trial
Current Status
Recruiting
Checked: October 21, 2026 at 10:07 PM UTC
| NCT Number | NCT07459647 |
| Recruiting Status | Recruiting |
| Condition | Schizophrenia |
| Phase | PHASE2 |
| Target Enrollment | 500 participants |
| Active Locations | 45 sites in the US |
| Sponsor | MapLight Therapeutics |
| Last Updated on CT.gov | October 15, 2026 (6 days ago) |
As of October 21, 2026: Clinical trial NCT07459647 is currently recruiting participants. This phase2 study for schizophrenia is actively seeking new participants at 45 locations across the United States. The study is sponsored by MapLight Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07459647 is actively recruiting participants as of October 21, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 45 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07459647 was last updated 6 days ago (October 15, 2026). HelloStudys verifies this status automatically.